Cipla arm secures marketing rights for cancer drug in US

Drug major Cipla today said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer treatment drug Capecitabine in the US market.

Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.

The company’s product is generic equivalent of Genentech’s Xeloda.

Capecitabine tablets are indicated in patients with colon cancer and for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.

As per IQVIA (IMS Health) dat, Xeloda and its generic equivalents had sales of around USD 178 million in the US for 12-month period ending June 2018.

Shares of Cipla today ended 0.27 per cent up at Rs 620.90 on the BSE.

  • Related Posts

    • Pharma
    • May 16, 2024
    • 46 views
    CDSCO Approves Antibody For Rare Skin Disorder In Indian Adults

    Mumbai: The Central Drugs Standard Control Organisation (CSDCO) on Wednesday approved Boehringer Ingelheim’s Spevigo (Spesolimab) injection, a first-in-class treatment for adults suffering from Generalised Pustular Psoriasis (GPP) flares — a…

    • Pharma
    • May 16, 2024
    • 85 views
    Delhi HC Directs Petitioners To File Joint Written Submission On FDC Ban Issue

    New Delhi: The Division Bench of Delhi High Court, which is hearing the petitions by pharmaceutical manufacturers against the Central government’s order prohibiting 14 fixed dose combinations (FDCs), has directed the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CDSCO Approves Antibody For Rare Skin Disorder In Indian Adults

    CDSCO Approves Antibody For Rare Skin Disorder In Indian Adults

    Delhi HC Directs Petitioners To File Joint Written Submission On FDC Ban Issue

    Delhi HC Directs Petitioners To File Joint Written Submission On FDC Ban Issue

    Assam: 1000 Bottles of Cough Syrup Seized, One Arrested in Kharupetia

    Assam: 1000 Bottles of Cough Syrup Seized, One Arrested in Kharupetia

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    DCA Forms Task Force To Investigate Smilax And Biogenetic Operations

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification

    CDSCO Constitutes Eight-Member Subcommittee To Look Into OTC Classification